General Information
Revision date
2025-11-28
Product name
Nalidixic Selective Supplement
1.2.1 Relevant identified uses
Biochemical research/analysis, Laboratory chemicals, Analytical purpose
Icons in SDS
Company Information
company name
Microxpress Division of Tulip Diagnostics (P) Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
sales@tulipgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves. P342+P311 IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
Supplemental label elements
None.
2.3 Other hazards
None
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 (EU-GHS/CLP) Sensitisation, Skin, (Category 1), H317 Sensitisation, respiratory (Category 1), H334
